ID   KITi001-C-41
AC   CVCL_B0PH
SY   ACTA2-EGFP hiPSC 3-41; ACTA2-EGFP clone 3-41
DR   Wikidata; Q108820626
RX   PubMed=34481189;
CC   From: Korea Institute of Toxicology; Daejeon; South Korea.
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a EGFP-polyA-PGKp-neo construct was introduced at the C-terminus of one allele of ACTA2 (PubMed=34481189).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VE24 ! KITi001-A
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
RX   PubMed=34481189; DOI=10.1016/j.scr.2021.102524;
RA   Jo S., Kim J.-W., Noh H., Kim H., Kim J.-H., Park H.-J.;
RT   "Generation of an ACTA2-EGFP reporter human induced pluripotent stem
RT   cell line, KITi001-C-41, using CRISPR/Cas9-mediated homologous
RT   recombination.";
RL   Stem Cell Res. 56:102524-102524(2021).
//